Acceptance of High Platelet Reactivity as a Risk Factor

被引：12

作者：

Gurbel, Paul A. ^{[1
]}

Tantry, Udaya S. ^{[1
]}

机构：

[1] Sinai Hosp Baltimore, Cardiac Catheterizat Lab, Sinai Ctr Thrombosis Res, Baltimore, MD 21215 USA

来源：

JACC-CARDIOVASCULAR INTERVENTIONS | 2010年 / 3卷 / 10期

关键词：

clopidogrel; high platelet reactivity; loss-of-function allele; ELUTING STENT IMPLANTATION; DUAL-ANTIPLATELET THERAPY; CLOPIDOGREL RESISTANCE; CORONARY INTERVENTION; ASSOCIATION; INHIBITION; CONSENSUS; EVENTS;

D O I：

10.1016/j.jcin.2010.08.011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1008 / 1010

页数：3

共 21 条

[1]

[Anonymous], FDA DRUG SAF COMM RE

[2] Pilot Study of the Antiplatelet Effect of Increased Clopidogrel Maintenance Dosing and Its Relationship to CYP2C19 Genotype in Patients With High On-Treatment Reactivity [J].

Barker, Colin M. ;

Murray, Sarah S. ;

Teirstein, Paul S. ;

Kandzari, David E. ;

Topol, Eric J. ;

Price, Matthew J. .

JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (10) :1001-1007

[3]

Bliden K, 2009, CIRCULATION, V120, pS1172

[4] Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: A multicenter randomized prospective study [J].

Bonello, Laurent ;

Camoin-Jau, Laurence ;

Arques, Stephane ;

Boyer, Christian ;

Panagides, Dimitri ;

Wittenberg, Olivier ;

Simeoni, Marie-Claude ;

Barragan, Paul ;

Dignat-George, Francoise ;

Paganelli, Franck .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (14) :1404-1411

[5] Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate [J].

Bonello, Laurent ;

Tantry, Udaya S. ;

Marcucci, Rossella ;

Blindt, Ruediger ;

Angiolillo, Dominick J. ;

Becker, Richard ;

Bhatt, Deepak L. ;

Cattaneo, Marco ;

Collet, Jean Philippe ;

Cuisset, Thomas ;

Gachet, Christian ;

Montalescot, Gilles ;

Jennings, Lisa K. ;

Kereiakes, Dean ;

Sibbing, Dirk ;

Trenk, Dietmar ;

Van Werkum, Jochem W. ;

Paganelli, Franck ;

Price, Matthew J. ;

Waksman, Ron ;

Gurbel, Paul A. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (12) :919-933

[6] Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel [J].

Brandt, J. T. ;

Close, S. L. ;

Iturria, S. J. ;

Payne, C. D. ;

Farid, N. A. ;

Ernest, C. S., II ;

Lachno, D. R. ;

Salazar, D. ;

Winters, K. J. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (12) :2429-2436

[7] The Case for Routine Genotyping in Dual-Antiplatelet Therapy [J].

Damani, Samir B. ;

Topol, Eric J. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (02) :109-111

[8] The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to cyp 2c19*2 genotype: first experience in patients [J].

Gurbel, P. A. ;

Bliden, K. P. ;

Antonino, M. J. ;

Stephens, G. ;

Gretler, D. D. ;

Jurek, M. M. ;

Pakyz, R. E. ;

Shuldiner, A. R. ;

Conley, P. B. ;

Tantry, U. S. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (01) :43-53

[9] Clopidogrel for coronary stenting - Response variability, drug resistance, and the effect of pretreatment platelet reactivity [J].

Gurbel, PA ;

Bliden, KP ;

Hiatt, BL ;

O'Connor, CM .

CIRCULATION, 2003, 107 (23) :2908-2913

[10] Clopidogrel loading with eptifibatide to arrest the reactivity of platelets - Results of the clopidogrel loading with eptifibatide to arrest the reactivity of platelets (CLEAR PLATELETS) study [J].

Gurbel, PA ;

Bliden, KP ;

Zaman, KA ;

Yoho, JA ;

Hayes, KM ;

Tantry, US .

CIRCULATION, 2005, 111 (09) :1153-1159

← 1 2 3 →